ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine
(group practice)

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,636Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 178

$548K Total Retail Price of All Prescriptions

Rank: 8 out of 178

314 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in District of Columbia
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 314 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 314 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,504 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
AMLODIPINE BESYLATE 572 522 1 1
LISINOPRIL 539 483 2 2
SIMVASTATIN 443 405 3 3
FUROSEMIDE 343 298 4 6
OMEPRAZOLE 258 240 5 9
LEVOTHYROXINE SODIUM 241 206 6 8
OXYCODONE-ACETAMINOPHEN 237 167 S2 7 31
HYDROCHLOROTHIAZIDE 227 204 8 5
METOPROLOL TARTRATE 198 181 9 10
POTASSIUM CHLORIDE 187 187 10 43
DONEPEZIL HCL 184 184 11 29
METFORMIN HCL 179 158 12 7
ATORVASTATIN CALCIUM 178 143 13 4
RISPERIDONE 170 148 14 61
MIRTAZAPINE 164 163 15 47
NEXIUM 129 123 16 25
SERTRALINE HCL 128 122 17 32
LANTUS 127 121 18 26
CARVEDILOL 125 125 19 27
DIOVAN 121 121 20 23
NAMENDA 118 107 21 53
METOPROLOL SUCCINATE 114 114 22 11
WARFARIN SODIUM 108 99 23 15
GLIPIZIDE 107 98 24 18
CLOPIDOGREL 100 98 25 36
QUETIAPINE FUMARATE 96 95 26 59
CLONIDINE HCL 95 82 27 28
HYDRALAZINE HCL 95 94 27 24
ALENDRONATE SODIUM 93 92 29 33
LATANOPROST 89 89 30 77
LOVASTATIN 86 80 31 22
KLOR-CON M20 85 80 32 41
LEVETIRACETAM 82 80 33 69
FAMOTIDINE 82 80 33 73
TAMSULOSIN HCL 80 67 35 40
PLAVIX 79 79 36 54
DIVALPROEX SODIUM 78 78 37 95
GABAPENTIN 73 45 38 14
POLYETHYLENE GLYCOL 3350 69 54 39 60
TRAMADOL HCL 69 61 39 30
PAROXETINE HCL 69 69 39 145
LYRICA 67 67 42 86
NOVOLOG 65 60 43 85
ZOLPIDEM TARTRATE 64 58 44 16
AMOX TR-POTASSIUM CLAVULANATE 64 60 44 151
TRAZODONE HCL 61 61 46 57
GENERLAC 61 61 46 158
RANITIDINE HCL 60 57 48 39
LACTULOSE 57 51 49 76
ATENOLOL 56 56 50 13
JANTOVEN 56 56 50 116
OLANZAPINE 55 46 52 94
AMLODIPINE BESYLATE-BENAZEPRIL 53 38 53 63
TRAVATAN Z 53 53 53 134
ALBUTEROL SULFATE 53 53 53 95
CRESTOR 50 39 56 17
HYDROCODONE-ACETAMINOPHEN 50 45 S3 56 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.